Genetic Strategy Reverses Insecticide Resistance
Noozhawk.com delivers local breaking news, local sports, schools, nonprofits, obituaries, business, arts and entertainment, calendar, local opinions and more.
Stay updated with breaking news from Synbal Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Noozhawk.com delivers local breaking news, local sports, schools, nonprofits, obituaries, business, arts and entertainment, calendar, local opinions and more.
The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute's Center for Infectious Disease and Vaccine Research.
The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute's Center for Infectious Disease and Vaccine Research.
Share this article Share this article SAN DIEGO, May 27, 2021 /PRNewswire/ -- Synbal, Inc., a privately held biotechnology company specializing in the development of genetically complex, humanized mouse models for research announced today that they have received a SBIR grant from the National Institute of Allergy and Infectious Diseases to develop a novel, humanized mouse model for Covid-19 therapeutics research. Synbal is partnering with La Jolla Institute for Immunology (LJI) to fully characterize the model that will then be made available in early 2022 to the research community to accel...
E-Mail IMAGE: Red fluorescent detector proteins in fruit flies reveal detection from an actual copying experiment (left) and how perfect copying would appear (right). Fluorescent cells in the left panel also lack... view more Credit: Zhiqian Li Researchers at the University of California San Diego have laid the groundwork for a potential new type of gene therapy using novel CRISPR-based techniques. Working in fruit flies and human cells, research led by UC San Diego Postdoctoral Scholar Zhiqian Li in Division of Biological Sciences Professor Ethan Bier's laboratory demonstrates th...